Prognostic Performance of the Next-Generation Sequencing-Based Multigene Assay in Early Breast Cancer Patients Treated According to the 21-Gene Assay Results
Eunhye Kang(Seoul National University), Jai Min Ryu(Samsung Medical Center), S. Lee(Ulsan College), Jiwon Koh(Seoul National University Hospital), Han‐Byoel Lee(Seoul National University Hospital), Jeongeun Son(ToolGen (South Korea)), Jong-Ho Cheun(Seoul National University), Jiyoung Park(Kyungpook National University Hospital), Jeeyeon Lee(Northwestern University), Bum Joon Kim(Asan Medical Center), Woosung Chung(ToolGen (South Korea)), Wonshik Han(Seoul National University), Woong Ki Park(Samsung Medical Center), Hee Jin Lee(Ulsan College)
Cited by 2
Related Papers
A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|Breast Cancer Research|2012|139
Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial
|The Lancet Neurology|2018|98
Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
|Oncotarget|2017|66
Genetic Polymorphisms of Ataxia Telangiectasia Mutated and Breast Cancer Risk
|Cancer Epidemiology Biomarkers & Prevention|2005|52
Recurrent fusion transcripts detected by whole‐transcriptome sequencing of 120 primary breast cancer samples
|Genes Chromosomes and Cancer|2015|49